Search the Newsreel

Deadline Alert: Insulet Corporation (PODD) Shareholders Who

Glancy Prongay Wolke & Rotter LLP is urging Insulet Corporation (NASDAQ: PODD) shareholders who lost money to contact them regarding a securities fraud lawsuit. The class action alleges Insulet made misleading statements and failed to disclose defective manufacturing controls, leading to product recalls and …

The Gross Law Firm Reminds Shareholders of a Lead Plaintiff

The Gross Law Firm is alerting shareholders of Insulet Corporation (NASDAQ: PODD) about a lead plaintiff deadline of August 31, 2026, in a class action lawsuit. The lawsuit alleges that Insulet made materially false and/or misleading statements regarding defective manufacturing controls that created a …

Poddar Pigments schedules 35th AGM for September 21, 2026

Poddar Pigments Q1FY27 net profit rises 12% YoY to ₹4.65 crore

Poddar Pigments Q1 Results: Net profit rises 12% YoY to ₹4.65 crore

Poddar Pigments standalone net profit rises 11.51% in the June 2026 quarter

Pomerantz Law Firm Announces the Filing of a Class Action Against Insulet Corporation and Certain Officers - PODD

Pomerantz LLP has filed a class action lawsuit against Insulet Corporation and certain officers, alleging that the company made materially false and misleading statements regarding its business, operations, and compliance policies between February 21, 2025, and May 26, 2026. The lawsuit claims that Insulet's …

Bronstein, Gewirtz & Grossman LLC Urges Insulet Corporation Investors to Act: Class Action Filed Alleging Investor Harm

Bronstein, Gewirtz & Grossman, LLC has filed a class action lawsuit against Insulet Corporation (NASDAQ: PODD) on behalf of investors who purchased securities between May 21, 2025, and May 26, 2026. The lawsuit alleges that Insulet made false and misleading statements about its manufacturing …

PODD DEADLINE: SueWallSt Reminds Insulet Corporation Investors of Upcoming Securities Class Action Deadline

SueWallSt is reminding investors of Insulet Corporation (NASDAQ: PODD) about an upcoming securities class action deadline on August 31, 2026. The lawsuit focuses on alleged defective cannula manufacturing that led to insulin under-delivery in millions of Omnipod devices and caused a significant decline in …

Contact Robbins LLP for Information About Leading the Lawsuit That Alleges Insulet Corporation Misled Investors Regarding the Safety and Reliability of its Insulin Delivery Products

Robbins LLP has filed a securities class action lawsuit against Insulet Corporation (NASDAQ: PODD) on behalf of investors who purchased securities between February 21, 2025, and May 26, 2026. The lawsuit alleges Insulet made misleading statements regarding its manufacturing controls and the safety of …

Insulet Corporation’s (PODD) Wearable Pod Tech Finds New Frontier

Alpha Wealth Funds, LLC, an investment management company, released its Q2 2026 letter for the "Insiders Fund". A copy of the letter is available to download here. The Fund lost 1.45% in June, while it was up 8.43% for the 2nd quarter and 0.75% …

Insulet Corporation (PODD) Stock forecasts

Argus has lowered its target price for Insulet Corporation (PODD) to $159.00 from its previous rating. Insulet, founded in 2000, aims to simplify continuous subcutaneous insulin infusion therapy for diabetes. The stock's current price is $144.68.

Insulet Deadline: PODD Investors with Losses in Excess of $100K Have Opportunity to Lead Insulet Corporation Securities Fraud Lawsuit

The Rosen Law Firm reminds investors who purchased Insulet Corporation (NASDAQ: PODD) securities between February 21, 2025, and May 26, 2026, of the August 31, 2026, lead plaintiff deadline for a securities fraud lawsuit. The lawsuit alleges that Insulet made false and misleading statements …

Insulet Corporation Investors With Significant Losses Must Act By August 31, 2026

Kirby McInerney LLP reminds Insulet Corporation (NASDAQ: PODD) investors with significant losses that the deadline to seek the role of lead plaintiff in a federal securities class action is August 31, 2026. The lawsuit alleges Insulet made misleading public statements regarding defective manufacturing controls …

Insulet hires Pfizer alum Joan Campion to lead external comms

Insulet, a medical device company, has appointed Joan Campion, formerly of Pfizer, as its new VP of external communications for corporate affairs. This new role is part of a broader effort by Insulet to enhance its communications function under Chief Corporate Affairs Officer Cristal …

Insulet (PODD) Q2 2026 Earnings Call Transcript

Insulet reported strong Q2 2026 results with 23% revenue growth and increased profitability, driven by demand for Omnipod. However, the company lowered its full-year revenue outlook due to lower-than-anticipated retention and utilization rates among Type 2 diabetes customers, particularly in the initial 90 days …

Insulet (PODD) Could Be 39% Undervalued After Strong Earnings And Higher 2026 Outlook

PODD Shareholder Alert: Insulet Corporation Securities Class Action Lawsuit - Investors With Losses May Contact Levi & Korsinsky

Levi & Korsinsky, LLP has issued a shareholder alert regarding a securities class action lawsuit against Insulet Corporation (NASDAQ: PODD). The lawsuit alleges that former EVP and COO Eric Benjamin made false statements about Omnipod product safety while selling $3.7 million in company stock. …

Lead Plaintiff Deadlines in Shareholder Class Action Lawsuits Against Hub Group, Inc. (HUBG), Insulet Corporation (PODD), and Photronics, Inc. (PLAB) Announced by Holzer & Holzer, LLC

Holzer & Holzer, LLC has announced lead plaintiff deadlines for shareholder class action lawsuits against Hub Group, Inc. (HUBG), Insulet Corporation (PODD), and Photronics, Inc. (PLAB). The lawsuits allege false or misleading statements regarding financial results, revenue recognition, internal controls, manufacturing controls, and product …

Insulet Corp. stock outperforms competitors on strong trading day

Insulet Corp. (PODD) saw its stock rise 1.30% to $144.70 on Tuesday, marking its fourth consecutive day of gains. This performance outpaced the broader market, as the S&P 500 Index and Dow Jones Industrial Average both experienced declines.

Insulet Corporation (PODD) Shareholders Who Lost Money Have Opportunity to Lead Securities Fraud Lawsuit

Glancy Prongay Wolke & Rotter LLP has announced that Insulet Corporation (PODD) shareholders who suffered losses between February 21, 2025, and May 26, 2026, have the opportunity to lead a securities fraud class action lawsuit. The lawsuit alleges that Insulet made materially false or …

Portnoy Law Firm Announces Class Action on Behalf of Insulet Corporation Investors

The Portnoy Law Firm has announced a class action lawsuit on behalf of investors in Insulet Corporation (NASDAQ: PODD). The lawsuit alleges that Insulet made false and misleading statements regarding defective manufacturing controls and procedures, which led to multiple medical device corrections for its …

Important Notice to Long-Term Shareholders of Erasca, Inc.

Grabar Law Office is investigating potential breaches of fiduciary duties by officers and directors of Erasca, Insulet Corporation, Power Solutions International, and PROCEPT BioRobotics Corporation. The investigations stem from alleged misleading statements, manufacturing issues, and other concerns that led to stock declines for these …

INSULET CLASS ACTION LAWSUIT ALERT: Bragar Eagel & Squire, P.C. Announces that a Class Action Lawsuit Has Been Filed Against Insulet Corporation and Encourages Investors to Contact the Firm

Bragar Eagel & Squire, P.C. has announced the filing of a class action lawsuit against Insulet Corporation (NASDAQ: PODD). The lawsuit, filed in the U.S. District Court for the District of Massachusetts, alleges that Insulet made materially false and misleading statements regarding its manufacturing …

Insulet Corporation (NASDAQ:PODD) Given Average Rating of "Hold" by Brokerages

Insulet Corporation (NASDAQ:PODD) has received a consensus "Hold" rating from brokerages, with an average 12-month price target of $195.40 despite several firms reducing their targets. The company exceeded quarterly expectations with $1.66 EPS and $801.7 million in revenue, but a reduced fiscal 2026 revenue …

Insulet Corporation $PODD Shares Sold by Assenagon Asset Management S.A.

Assenagon Asset Management S.A. significantly reduced its stake in Insulet Corporation (NASDAQ:PODD) by 67.2% in the second quarter of 2026, selling 173,086 shares and retaining 84,633 shares valued at approximately $12.9 million. This reduction comes despite Insulet exceeding second-quarter expectations with strong EPS and …

PODD SHAREHOLDER ALERT: Bronstein, Gewirtz and Grossman, LLC Announces that Insulet Corporation Investors Have Opportunity to Lead Class Action Lawsuit!

Bronstein, Gewirtz & Grossman, LLC has announced a class action lawsuit against Insulet Corporation (NASDAQ: PODD) and its officers for alleged violations of federal securities laws. The lawsuit claims that Insulet made materially false and misleading statements regarding defective manufacturing controls and procedures, creating …

Insulet Corp. stock underperforms Monday when compared to competitors despite daily gains

Insulet Corp. (PODD) stock saw a daily gain of 1.19% on Monday, closing at $142.85. Despite this increase, the stock underperformed against a general market downturn, with both the S&P 500 Index and Dow Jones Industrial Average recording slight declines. This marked the third …

PODD's Q2 Earnings Top Estimates, FY'26 Sales View Cut, Stock Down

Insulet Corporation PODD reported second-quarter 2026 adjusted earnings per share (EPS) of $1.66, up 41.5% year over year. The bottom line beat the Zacks Consensus Estimate by 15.28%. GAAP EPS came in at $1.37 compared with the year-ago quarter's figure of 32 cents. Revenues …

Insulet Corporation (PODD) Stock Analysis: Exploring a 21.77% Potential Upside in the Healthcare Sector

Insulet Corporation (PODD) is a U.S.-based medical device company specializing in innovative insulin delivery systems, holding a market capitalization of $9.79 billion. Analysts project a potential upside of 21.77% for its stock, with an average target price of $171.91, despite recent volatility. The company …

Insulet Corporation (NASDAQ:PODD) Just Reported, And Analysts Assigned A US$172 Price Target

Insulet Corporation's stock dropped 15% to US$141 despite reporting revenues in line with expectations and slightly better-than-expected statutory profits of US$1.37 per share. Analysts maintained their 2026 revenue and EPS forecasts at US$3.29 billion and US$6.17, respectively, but cut the consensus price target by …

Beacon Investment Advisory Services Inc. Has $9.03 Million Stock Holdings in Insulet Corporation $PODD

Beacon Investment Advisory Services Inc. reduced its stake in Insulet Corporation (NASDAQ:PODD) by 13.3% in the second quarter, now holding 59,333 shares valued at approximately $9.03 million. Despite Insulet reporting strong second-quarter revenues and adjusted EPS that beat analyst expectations, the company lowered its …

PODD Investors Have Opportunity to Lead Insulet Corporation Securities Fraud Lawsuit with SBS Law

Schall, Brown & Schwartz LLP (SBS) is reminding investors of a class action lawsuit against Insulet Corporation (NASDAQ: PODD) for alleged securities fraud. The lawsuit claims Insulet made false statements regarding defective manufacturing controls, increased safety violation risks, and the scope of a Medical …